ACCORD Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACCORD, and what generic alternatives to ACCORD drugs are available?
ACCORD has one hundred and fifty-five approved drugs.
There are four US patents protecting ACCORD drugs. There are three tentative approvals on ACCORD drugs.
There are thirty-five patent family members on ACCORD drugs in eighteen countries and three hundred and eighty-six supplementary protection certificates in eighteen countries.
Summary for ACCORD
International Patents: | 35 |
US Patents: | 4 |
Tradenames: | 132 |
Ingredients: | 129 |
NDAs: | 155 |
Patent Litigation for ACCORD: | See patent lawsuits for ACCORD |
PTAB Cases with ACCORD as petitioner: | See PTAB cases with ACCORD as petitioner |
Drugs and US Patents for ACCORD
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Accord Hlthcare | EPLERENONE | eplerenone | TABLET;ORAL | 206922-001 | Jul 13, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Accord Hlthcare | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 090843-003 | Feb 14, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Accord Hlthcare | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET;ORAL | 202152-003 | Mar 27, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Accord Hlthcare | METHYLDOPA | methyldopa | TABLET;ORAL | 070085-001 | Oct 15, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Accord Hlthcare | DOCETAXEL | docetaxel | INJECTABLE;INJECTION | 201195-005 | Apr 20, 2012 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACCORD drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
International Patents for ACCORD Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 111511385 | ⤷ Try a Trial |
Hong Kong | 1126975 | ⤷ Try a Trial |
New Zealand | 766167 | ⤷ Try a Trial |
Japan | 2009523798 | ⤷ Try a Trial |
Russian Federation | 2427383 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for ACCORD Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0477295 | SPC/GB99/046 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: EPTIFIBATIDE OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: CH 54054 19970227; CH 54050 19970227; UK EU/1/99/109/001 19990701; UK EU/1/99/109/002 19990701 |
0720599 | 03C0028 | France | ⤷ Try a Trial | PRODUCT NAME: EZETIMIBE; NAT. REGISTRATION NO/DATE: NL28237 20030611; FIRST REGISTRATION: DE - 54486.00.00 A 54489.00.00 20021017 |
2316456 | 65/2017 | Austria | ⤷ Try a Trial | PRODUCT NAME: NALTREXON ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE NALTREXONHYDROCHLORID, UND BUPROPION ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, INSBESONDERE BUPROPIONHYDROCHLORID; REGISTRATION NO/DATE: EU/1/14/988 (MITTEILUNG) 20150330 |
2316456 | 122017000109 | Germany | ⤷ Try a Trial | PRODUCT NAME: NALTREXON ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE NALTREXONHYDROCHLORID, UND BUPROPION ODER EIN PHARMAZEUTISCH AKZEPTABLES SALZ DAVON, INSBESONDERE BUPROPIONHYDROCHLORID; REGISTRATION NO/DATE: EU/1/14/988 20150326 |
0245997 | SPC/GB00/005 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: DOFETILIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/99/121/001 19991129; UK EU/1/99/121/002 19991129; UK EU/1/99/121/003 19991129; UK EU/1/99/121/004 19991129; UK EU/1/99/121/005 19991129; UK EU/1/99/121/006 19991129; UK EU/1/99/121/007 19991129; UK EU/1/99/121/008 19991129; UK EU/1/99/121/009 19991129; UK EU/1/99/121/010 19991129; UK EU/1/99/121/011 19991129; UK EU/1/99/121/012 19991129; UK EU/1/99/121/013 19991129; UK EU/1/99/121/014 19991129; UK EU/1/99/121/015 19991129 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.